CORE
đșđŠÂ
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
12 research outputs found
Commil v. Cisco
Author
Breath Ltd AstraZeneca LP v.
Eli Lilly &
Publication venue
'Future Science Ltd'
Publication date
Field of study
No full text
Crossref
Prolonged infusion of dexmedetomidine for sedation following tracheal resection
Author
AstraZeneca Pharmaceuticals LP
Deutch ES
+11Â more
Dyck JB
Hayashi Y
Jasinski DR
Parke TJ
Reisine T
Riker RR
Rothschild MA
Rowe RW
Segredo V
Shelly MP
Young CC
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Rosuvastatin: A Review of the Pharmacology and Clinical Effectiveness in Cardiovascular Disease
Author
AstraZeneca Pharmaceuticals LP.
Bo M.
+12Â more
Davidson M.H.
Gibson C.M.
Graham I.
Koren M.J.
Mora S.
Ridker P.M.
Ridker P.M.
Scandinavian Simvastatin Survival Study Group.
Scandinavian Simvastatin Survival Study Group.
Sever P.S.
White C.M.
White C.M.
Publication venue
'SAGE Publications'
Publication date
Field of study
No full text
Crossref
The Role of Irreversible HER Family Inhibition in the Treatment of Patients with NonâSmall Cell Lung Cancer
Author
AstraZeneca Pharmaceuticals LP
Awada A
+14Â more
Bos JL
Boyer MJ
Britten CD
Eunice Kwak
Gandhi L
Ganjoo KN
Genentech Inc
Janjigian YY
Janne PA
Miller VA
Park K
Porta R
Stavridi F
Yang C
Publication venue
'Alphamed Press'
Publication date
Field of study
No full text
Crossref
Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study
Author
Andrews
AstraZeneca Pharmaceuticals LP
+27Â more
Baigent
Barrios
Bays
Cannon
Cannon
Catapano
Constance
Davidson
Davidson
Friedewald
Goldberg
Graham
Grundy
Heart Protection Study Collaborative Group
Jones
Jones
Kindermann
Knopp
La Rosa
Laforest
LaRosa
MERCK/Schering-Plough Pharmaceuticals
Pedersen
Pisciotta
Reckless
Roeters van Lennep
Smith
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Potential cardiac risk of immune-checkpoint blockade as anticancer treatment: What we know, what we do not know, and what we can do to prevent adverse effects
Author
AstraZeneca Pharmaceuticals LP
Azuma
+67Â more
Brahmer
Bu
Caforio
Cochain
der Merwe
Dietel
Eggermont
Eggers
EMD Serono Inc
Eppihimer
Ewer
Ewing
Fallarino
Francisco
Friedman
Geisler
Genentech Inc
Genova
Grabie
Han
Heinzerling
Irving
Johnson
Ketelhuth
Khan
Koelzer
Kuo
Larkin
Latchman
Liu
Liu
Love
Lucas
LĂ€ubli
Mahajan
Matsumoto
Mellman
Moslehi
Nghiem
Nishimura
Nogueira
Okazaki
Okazaki
Papageorgiou
Pico de Coaña
Pillai
Postow
Qureshi
Rodriguez
Rosenberg
Roth
Rudd
Ruppert
Seko
Seliger
Sharpe
Slamon
Taqueti
Tarrio
Tivol
Wang
Wang
Waterhouse
Xiao
Yip
Yun
Zimmer
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Adverse Effects of Psychotropic Medications on Sleep
Author
Armitage
Armitage
+66Â more
AstraZeneca Pharmaceuticals LP
Baughman
Beasley
Benca
Berry
Chatoor
Dorsey
Dursun
Forest Pharmaceuticals USA Inc
Forest Pharmaceuticals USA Inc
Fuller
Gao
Gillin
Grasmader
Hendrickse
Hinze-Selch
Karl Doghramji
Keck
Kent
Kerkhofs
Kim
Krystal
Kupfer
Kupfer
Kupfer
Lam
Luthringer
Luthringer
Markov
Monti
Mouret
Nofzinger
Nofzinger
Organon USA
Organon Inc
Perroud
Pratt
Reynolds
Rittmannsberger
Robert
Roth
Rottach
Sadeh
Salin-Pascual
Salin-Pascual
Saper
Scharf
Schenck
Sharpley
Sharpley
Shipley
Stahl
Stein
Takeda Pharmaceuticals America Inc
Taylor
Touyz
Trivedi
Vasar
Vogel
Ware
Wetter
Wiegand
Wigal
William C. Jangro
Winokur
Wyatt
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
1
2